IL142063A0 - Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same - Google Patents
Tetrahydropyridoether derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL142063A0 IL142063A0 IL14206399A IL14206399A IL142063A0 IL 142063 A0 IL142063 A0 IL 142063A0 IL 14206399 A IL14206399 A IL 14206399A IL 14206399 A IL14206399 A IL 14206399A IL 142063 A0 IL142063 A0 IL 142063A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydropyridoether
- derivatives
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PWILYDZRJORZDR-MISYRCLQSA-N (7r,8r,9r)-7-(2-methoxyethoxy)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8-ol Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(C4=NC(C)=C(C)N4C=C3)N2)OCCOC)=CC=CC=C1 PWILYDZRJORZDR-MISYRCLQSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843504 | 1998-09-23 | ||
| EP98117988 | 1998-09-23 | ||
| PCT/EP1999/006899 WO2000017200A1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142063A0 true IL142063A0 (en) | 2002-03-10 |
Family
ID=26049024
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14206399A IL142063A0 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same |
| IL142063A IL142063A (en) | 1998-09-23 | 2001-03-18 | History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL142063A IL142063A (en) | 1998-09-23 | 2001-03-18 | History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US6436953B1 (https=) |
| EP (1) | EP1115725B1 (https=) |
| JP (1) | JP4145492B2 (https=) |
| KR (1) | KR100668400B1 (https=) |
| CN (2) | CN1155598C (https=) |
| AT (1) | ATE231862T1 (https=) |
| AU (1) | AU763463B2 (https=) |
| BG (1) | BG65195B1 (https=) |
| BR (1) | BR9914044A (https=) |
| CA (1) | CA2344251A1 (https=) |
| CZ (1) | CZ292335B6 (https=) |
| DE (1) | DE69905178T2 (https=) |
| DK (1) | DK1115725T3 (https=) |
| EA (1) | EA005377B1 (https=) |
| EE (1) | EE04677B1 (https=) |
| ES (1) | ES2191464T3 (https=) |
| GE (1) | GEP20032926B (https=) |
| HK (1) | HK1038360B (https=) |
| HR (1) | HRP20010224A2 (https=) |
| HU (1) | HUP0102990A3 (https=) |
| ID (1) | ID28896A (https=) |
| IL (2) | IL142063A0 (https=) |
| NO (1) | NO317304B1 (https=) |
| NZ (1) | NZ510610A (https=) |
| PL (1) | PL193616B1 (https=) |
| PT (1) | PT1115725E (https=) |
| RS (1) | RS50145B (https=) |
| SI (1) | SI1115725T1 (https=) |
| SK (1) | SK285165B6 (https=) |
| TR (1) | TR200100805T2 (https=) |
| WO (1) | WO2000017200A1 (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436953B1 (en) * | 1998-09-23 | 2002-08-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
| WO2000063211A1 (en) * | 1999-04-17 | 2000-10-26 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Haloalkoxy imidazonaphthyridines |
| CA2285516C (en) * | 1999-05-12 | 2010-12-07 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
| CA2404477A1 (en) * | 2000-03-29 | 2001-10-04 | Altana Pharma Ag | Tricyclic imidazopyridines |
| SK286850B6 (sk) * | 2000-03-29 | 2009-06-05 | Altana Pharma Ag | Prekurzory imidazopyridínových derivátov, farmaceutický prostriedok s ich obsahom a ich použitie |
| EA008151B1 (ru) * | 2000-10-25 | 2007-04-27 | Алтана Фарма Аг | Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| MXPA03007888A (es) * | 2001-03-08 | 2003-12-04 | Astrazeneca Ab | Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos. |
| HUP0400379A3 (en) | 2001-08-02 | 2007-10-29 | Altana Pharma Ag | Tricyclic epoxides and their use for the preparation of pharmaceutically active agents |
| PL368586A1 (en) * | 2001-08-03 | 2005-04-04 | Altana Pharma Ag | Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| US20040235882A1 (en) * | 2001-08-03 | 2004-11-25 | Jorg Senn-Bilfinger | Amino-substituted imidazopyridines for the treatment of gastrointestial diseases |
| US7314935B2 (en) | 2002-02-15 | 2008-01-01 | Altana Pharma Ag | Tricyclic n-acyl compounds |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| RS95304A (sr) * | 2002-05-07 | 2006-12-15 | Altana Pharma Ag. | Nova kombinacija za tretman oboljenja disajnih puteva |
| AU2003288071A1 (en) | 2002-11-19 | 2004-06-15 | Altana Pharma Ag | 8-substituted imidazopyridines |
| US7879833B2 (en) | 2002-12-12 | 2011-02-01 | Nycomed Gmbh | Combination medicament |
| HRP20050632A2 (hr) * | 2002-12-20 | 2006-04-30 | Altana Pharma Ag | Silil eteri |
| MXPA05008490A (es) * | 2003-02-17 | 2005-10-18 | Altana Pharma Ag | Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias. |
| ES2335498T3 (es) | 2003-03-10 | 2010-03-29 | Nycomed Gmbh | Nuevo proceso para la preparacion de reflumilast. |
| TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
| SA04250092B1 (ar) * | 2003-05-14 | 2008-05-04 | التانا فاروا ايه جي | مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً |
| WO2004105795A1 (en) * | 2003-05-27 | 2004-12-09 | Altana Pharma Ag | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| KR20060118421A (ko) * | 2003-08-29 | 2006-11-23 | 다이노젠 파마세우티컬스, 인코포레이티드 | 위장 운동 장애의 치료에 유용한 조성물 |
| PT1670482E (pt) | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Utilização de ciclesonida para o tratamento de doenças respiratórias |
| KR20060099524A (ko) * | 2003-11-03 | 2006-09-19 | 아스트라제네카 아베 | 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체 |
| WO2005058894A1 (en) | 2003-12-19 | 2005-06-30 | Altana Pharma Ag | Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| NZ549011A (en) * | 2004-02-17 | 2009-04-30 | Altana Pharma Ag | Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| CA2579127C (en) | 2004-09-03 | 2011-08-02 | Yuhan Corporation | Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
| KR100958829B1 (ko) | 2004-09-03 | 2010-05-25 | 주식회사유한양행 | 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법 |
| ATE518858T1 (de) | 2004-09-03 | 2011-08-15 | Yuhan Corp | Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür |
| US8663694B2 (en) * | 2005-03-16 | 2014-03-04 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| EP2080513A1 (en) | 2008-01-16 | 2009-07-22 | Schraermeyer, Ulrich, Prof. Dr. rer. nat | Tetrahydropyridoethers for treatment of AMD |
| KR101605063B1 (ko) * | 2009-07-09 | 2016-03-21 | 라퀄리아 파마 인코포레이티드 | 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제 |
| WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
| JP6001168B2 (ja) * | 2012-06-15 | 2016-10-05 | バイオ‐ファーム ソリューションズ カンパニー リミテッドＢｉｏ‐Ｐｈａｒｍ Ｓｏｌｕｔｉｏｎｓ Ｃｏ．， Ｌｔｄ． | フェニルアルキルスルファメート化合物及びこれを含む筋弛緩剤組成物 |
| EP3054949A1 (en) | 2013-10-08 | 2016-08-17 | Katairo GmbH | Tetrahydropyridoethers for the treatment of stargardt's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
| WO1989000570A1 (fr) * | 1987-07-16 | 1989-01-26 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Nouveaux diazoles |
| SE9401197D0 (sv) * | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
| EP0773945A1 (de) * | 1994-07-28 | 1997-05-21 | Byk Gulden Lomberg Chemische Fabrik GmbH | Acylimidazopyridine |
| EP0971922B1 (en) * | 1997-03-24 | 2004-04-28 | ALTANA Pharma AG | Tetrahydropyrido compounds |
| EA002402B1 (ru) * | 1997-03-24 | 2002-04-25 | Бык Гульден Ломберг Хемише Фабрик Гмбх | Тетрагидропиридо-соединения |
| US6436953B1 (en) | 1998-09-23 | 2002-08-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
-
1999
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
- 1999-09-17 EE EEP200100172A patent/EE04677B1/xx not_active IP Right Cessation
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active Expired - Fee Related
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en not_active Ceased
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 HK HK02100042.6A patent/HK1038360B/en not_active IP Right Cessation
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
- 1999-09-17 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
-
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
-
2002
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
-
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142063A0 (en) | Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same | |
| HUP0104204A3 (en) | Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof | |
| AU2001230892A1 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same | |
| HUP0101813A3 (en) | Carboxylic acid derivatives substituted by homo- or heterocyclic group preparation method and pharmaceutical compositions containing them | |
| CA2216535A1 (en) | Protein kinase c inhibitors | |
| IL136145A0 (en) | Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof | |
| HUP9900457A3 (en) | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| HUP0102425A3 (en) | Imidazo pyridine derivatives which inhibit gastric acid secretion, process for producing them and pharmaceutical compositions containing them | |
| HUP0103913A3 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
| AU4949800A (en) | 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives | |
| HUP0000450A3 (en) | The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases | |
| HUP0204157A3 (en) | 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same | |
| HUP0002171A3 (en) | Aminophosphonic acid derivatives, method for their preparation and pharmaceutical compositions thereof | |
| HUP0104164A3 (en) | Imidazo[4,5-c]-pyridine-4-one derivatives with factor xa inhibiting effect, pharmaceutical compositions containing the same and process for their preparation | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| EP1411056A3 (en) | Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation | |
| PL352280A1 (en) | Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives | |
| HUP0105054A3 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation | |
| IL141165A0 (en) | New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same | |
| HUP0103004A3 (en) | Substituted imidazo[1,2a]azines as selective inhibitors of cox-2, process for their preparation and pharmaceutical compositions containing them | |
| NZ272089A (en) | Quinoline and benzimidazole derivatives; compounds, preparation and pharmaceutical compositions | |
| HUP0202988A3 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| AU5762099A (en) | The preparation of (n)-substituted-hydroxycycloalkylamine derivatives | |
| PL328123A1 (en) | Derivatives of banzo[c]quinolysine and method of obtaining them | |
| AU5101798A (en) | Method for oral administration of buspirone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |